Transient Abnormal Myelopoeisis and Mosaic Down Syndrome in a Phenotypically Normal Newborn.

GATA1 TAM acute megakaryocytic leukemia (AMKL) down syndrome mosaic down syndrome transient myeloproliferative disease trisomy 21

Journal

Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936

Informations de publication

Date de publication:
28 May 2020
Historique:
received: 15 04 2020
revised: 18 05 2020
accepted: 26 05 2020
entrez: 3 6 2020
pubmed: 3 6 2020
medline: 3 6 2020
Statut: epublish

Résumé

Transient abnormal myelopoiesis (TAM) is a common and potentially fatal neonatal complication of newborn babies with Down syndrome (DS). Children born with mosaic DS are also at risk of developing TAM. However, due to their variable phenotypes, early identification of patients with mosaic DS may be difficult; thus, early diagnosis of TAM is just as challenging. In this report, we describe a case of a phenotypically normal newborn who presented with concerns for neonatal leukemia. The diagnosis of mosaic DS and TAM was confirmed with abnormal

Identifiants

pubmed: 32481622
pii: children7060052
doi: 10.3390/children7060052
pmc: PMC7346181
pii:
doi:

Types de publication

Case Reports

Langues

eng

Références

Pediatr Blood Cancer. 2011 Feb;56(2):331-2
pubmed: 21157904
Eur J Haematol. 2015 May;94(5):456-62
pubmed: 24853125
Pediatr Blood Cancer. 2017 Aug;64(8):
pubmed: 28097792
Blood. 2004 Jan 15;103(2):399-406
pubmed: 14512321
Br J Haematol. 2018 Jul;182(2):200-211
pubmed: 29916557
Pediatr Int. 2019 Mar;61(3):222-229
pubmed: 30593694
Arch Dis Child Fetal Neonatal Ed. 1998 Nov;79(3):F215-7
pubmed: 10194996
Br J Haematol. 2003 Mar;120(6):930-8
pubmed: 12648061
J Pediatr Hematol Oncol. 2011 Aug;33(6):e261-3
pubmed: 21768885
Pediatr Blood Cancer. 2017 Mar;64(3):
pubmed: 27682159
J Pediatr Hematol Oncol. 2012 Aug;34(6):475-9
pubmed: 22510770
Ann Hematol. 2005 Apr;84(4):274-5
pubmed: 15605245
Curr Genomics. 2010 Sep;11(6):409-19
pubmed: 21358985
J Clin Oncol. 2011 Mar 20;29(9):e230-3
pubmed: 21205752
Mol Cell Pediatr. 2016 Dec;3(1):30
pubmed: 27510896
Br J Haematol. 2018 Jul;182(2):170-184
pubmed: 29806701

Auteurs

Zachary Prudowsky (Z)

Department of Hematology-Oncology, Texas Children's Hospital, Houston, TX 77030, USA.
Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.

HyoJeong Han (H)

Department of Hematology-Oncology, Texas Children's Hospital, Houston, TX 77030, USA.
Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.

Alexandra Stevens (A)

Department of Hematology-Oncology, Texas Children's Hospital, Houston, TX 77030, USA.
Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.

Classifications MeSH